Actinium Pharmaceuticals ... (ATNM)
undefined
undefined%
At close: undefined
1.39
0.36%
After-hours Jan 07, 2025, 08:00 PM EST

Balance Sheet (Annual)

Get detailed breakdowns of the balance-sheet with total debts, total investments, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10 FY09 FY08 FY07 FY06
Cash & Equivalents 76.68M 108.91M 77.83M 63.56M 9.25M 13.67M 17.40M 20.52M 25.64M 6.71M 5.53M 5.62M 150.00 150.00 2.12K 2.22K 6.43K 466.00
Short-Term Investments n/a n/a n/a n/a n/a n/a n/a n/a n/a 11.35K n/a n/a n/a n/a n/a n/a n/a n/a
Long-Term Investments n/a 302.00K n/a 391.00K 391.33K 49.86K 49.86K 49.86K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Assets 313.00K n/a -639.00K 50.00K 49.86K 391.13K 390.94K n/a n/a 34.73K n/a -3.01K n/a n/a n/a n/a n/a n/a
Receivables n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 237.83K n/a n/a n/a n/a n/a
Inventory n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Current Assets 1.59M 2.03M 1.92M 1.36M 785.72K 656.30K 439.32K 1.87M 838.20K 699.85K 431.03K 334.29K 257.63K n/a n/a n/a n/a n/a
Total Current Assets 78.26M 110.94M 79.75M 64.92M 10.09M 14.33M 17.84M 22.39M 26.48M 7.41M 5.75M 5.79M 150.00 150.00 2.12K 2.22K 6.43K 466.00
Property-Plant & Equipment 2.87M 2.95M 639.00K 1.03M 1.14M 118.80K 57.35K 88.55K 106.11K 127.70K 13.92K 3.01K n/a n/a n/a n/a n/a n/a
Goodwill & Intangibles n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Long-Term Assets 3.18M 3.25M 639.00K 1.47M 1.58M 559.79K 498.15K 138.41K 106.11K 162.43K 13.92K 3.01K n/a n/a n/a n/a n/a n/a
Total Assets 81.44M 114.19M 80.39M 66.40M 11.67M 14.89M 18.34M 22.53M 26.59M 7.57M 5.77M 5.79M 150.00 150.00 2.12K 2.22K 6.43K 466.00
Account Payables 7.95M 10.13M 5.54M 4.34M 4.60M 5.81M 4.65M 4.19M 1.47M 2.28M 378.95K 897.04K 644.51K 13.69K 13.50K 12.36K 2.36K 3.50K
Deferred Revenue n/a 35.00M 998.00K -4.34M -4.60M -6.06M n/a n/a 25.00K 214.36K 81.19K 31.18K n/a n/a n/a n/a n/a n/a
Short-Term Debt 541.00K 996.00K 614.00K 854.00K 746.00K 249.24K n/a n/a 265.69K 283.55K 157.82K 140.00K 124.36K n/a n/a n/a n/a n/a
Other Current Liabilities n/a -498.00K 691.00K -427.00K -367 n/a 15.92K 325.68K 2.87M 6.92M 6.79M 3.61M -742.56K 22.37K 16.40K 13.99K 1.32K 870.00
Total Current Liabilities 8.49M 10.63M 6.84M 4.77M 5.34M 6.06M 4.67M 4.52M 4.61M 9.49M 7.33M 4.64M 26.31K 36.06K 29.90K 26.35K 3.68K 4.37K
Long-Term Debt 1.57M 2.08M 3.00K 311.00K 682.00K 13.35K n/a n/a n/a n/a n/a n/a n/a 58.71K 68.51K 49.83K 35.96K 14.50K
Other Long-Term Liabilities n/a n/a n/a n/a 311.00 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Long-Term Liabilities 36.57M 37.08M 3.00K 311.00K 682.31K 13.35K n/a n/a n/a n/a n/a n/a 58.17K 58.71K 68.51K 49.83K 35.96K 14.50K
Total Liabilities 45.07M 47.71M 6.84M 5.08M 6.03M 6.08M 4.67M 4.52M 4.61M 9.49M 7.33M 4.64M 84.48K 94.77K 98.41K 76.18K 39.64K 18.87K
Total Debt 2.11M 2.58M 310.00K 738.00K 1.43M 262.59K n/a n/a 265.69K 283.55K 157.82K 140.00K 120.00K 60.00K 68.51K 49.83K 35.96K 14.50K
Common Stock 28.00K 26.00K 22.00K 18.00K 164.70K 115.70K 80.07K 55.80K 44.07K 29.97K 24.57K 213.92K 111.55K 111.55K 111.55K 23.10K 23.10K 23.10K
Retained Earnings -337.58M -288.76M -255.75M -230.97M -208.76M -186.86M -163.15M -136.55M -112.23M -91.20M -66.52M -55.74M -259.76K -270.05K -271.73K -249.40K -208.64K -193.84K
Comprehensive Income n/a -0.00 -0.00 n/a 0.00 -266.38K -215.66K -170.45K -92.93K -39.47K -1.56K -55.74M n/a n/a n/a n/a n/a n/a
Shareholders Equity 36.38M 66.48M 73.55M 61.32M 5.64M 8.81M 13.67M 18.01M 21.97M -1.92M -1.56M 1.15M -84.33K -94.62K -96.29K -73.96K -33.20K -18.40K
Total Investments 313.00K 302.00K n/a 391.00K 391.33K 49.86K 49.86K 49.86K n/a 11.35K n/a n/a n/a n/a n/a n/a n/a n/a